Skip to content

ULTRASCORE US141503H4Recalls & reported problems

Bard Peripheral Vascular, Inc. · ULTRASCORE™ Focused Force PTA Balloon 3.5mm x 40mm, 150cm catheter · Class 2

All models of ULTRASCORE (61)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741113574), received between Sep 9, 2021 and Sep 9, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Device-Device Incompatibility” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Device-Device Incompatibility1
  • Difficult to Advance1
  • Difficult to Remove1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 9, 2021Difficult to Remove; Device-Device Incompatibility; Difficult to Advance; Difficult to Remove; Device-Device Incompatibility; Difficult to Advance

    IT WAS REPORTED THAT DURING AN ANGIOPLASTY PROCEDURE, THE PTA BALLOON ALLEGEDLY HAD RESISTANCE WHILE LOADING ON GUIDEWIRE. IT WAS FURTHER REPORTED THAT AFTER DEFLATION THE WIRE GOT STUCK AND UNABLE TO RETRIEVE THE BALLOON. REPORTEDLY PHYSICIAN HAD TO REMOVE BOTH THE BALLOON AND WIRE AS A UNIT. THERE WAS NO REPORTED PATIENT INJURY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12445079 ↗

Other Catheter, percutaneous, cutting/scoring devices

All Catheter, percutaneous, cutting/scoring devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page